| # | Drug | Count |
|---|---|---|
| 0 | SUNITINIB MALATE | 974 |
| 1 | CABOZANTINIB | 504 |
| 2 | PAZOPANIB HYDROCHLORIDE | 278 |
| 3 | SORAFENIB | 274 |
| 4 | AXITINIB | 244 |
| 5 | OMEPRAZOLE MAGNESIUM | 226 |
| 6 | METHOTREXATE SODIUM | 213 |
| 7 | ASPIRIN | 189 |
| 8 | METHOTREXATE | 189 |
| 9 | PREDNISONE | 181 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEMSIROLIMUS | 136 | 0.0302 |
| 1 | SUNITINIB MALATE | 974 | 0.0249 |
| 2 | SORAFENIB | 274 | 0.0132 |
| 3 | AXITINIB | 244 | 0.0125 |
| 4 | CABOZANTINIB | 504 | 0.0104 |
| 5 | PAZOPANIB HYDROCHLORIDE | 278 | 0.0103 |
| 6 | BASILIXIMAB | 63 | 0.0053 |
| 7 | ERGOCALCIFEROL | 122 | 0.0041 |
| 8 | EVEROLIMUS TABLETS | 64 | 0.0037 |
| 9 | EVEROLIMUS | 180 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 757 |
| 1 | Corticosteroid [EPC] | 486 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 354 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 271 |
| 4 | Proton Pump Inhibitor [EPC] | 245 |
| 5 | mTOR Inhibitor Immunosuppressant [EPC] | 193 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 192 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 188 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 187 |
| 9 | Loop Diuretic [EPC] | 186 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 1 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 2 | Provitamin D2 Compound [EPC] | 122 | 0.0041 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 32 | 0.0017 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 3 | 0.0015 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 6 | Kinase Inhibitor [EPC] | 757 | 0.0014 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 125 | 0.0013 |
| 8 | Selective T Cell Costimulation Blocker [EPC] | 6 | 0.0013 |
| 9 | Androgen [EPC] | 33 | 0.0012 |